Get more information on Pharmaceuticals logistics Market - Request Sample Report
The global pharmaceutical logistics market, valued at USD 92.20 Billion in 2023, is projected to reach USD 201.99 Billion by 2032, growing at a compound annual growth rate CAGR of 9.59% during the forecast period.
Logistics is an essential element in the pharmaceuticals industry, the basic functionality of the pharma logistics is to store the drugs and carry out the process of delivery of drugs to the end user, The basic components of the pharmaceutical logistics are manufacturer, retailers, outlets, transportation, packaging and handling and so forth, The major objective of the pharmaceutical logistics is to deliver the drugs from the manufacturer to the end user without damaging the quality of the drugs and delivering the drug within time, time is essential element for the pharmaceutical logistics sector because of the rising demand for the drugs and the availability factor of drugs in the hospitals, it all depends on the requirement and the need and also the objective which are set by the logistics company, the intermediaries selection of the logistics companies during the supply chain management is the important factor which further decides the time management and the delivery date of the drugs, there has been a continues upgradation in the supply chain management in the pharmaceutical industry over the past years because of the rise in demand of the drugs all around the globe, the emerging countries though suffer because of the lack of infrastructure and the economic condition of the nation.
The initiative taken by the World Health Organization (WHO) regarding the products that fail to meet the drug standards and to prove it fatal after the lab test, makes the logistical companies to be more aware about hygiene during transportation because this can lead to deaths of humans.
The rise in the demand for the cold chain logistics during the covid-19 as the vaccines were required to be preserve in the containers with certain temperature and the cases of vaccines quality drop was increasing which led to the rise in the demand of the cold chain logistics and also the new innovation and upgradation in the drugs which required specific logistics is the challenging factor for the pharmaceutical’s logistics.
Covid 19 made it difficult for the pharmaceuticals to develop new products because of the shortage of raw materials and lack of clinical trials, the rise in the demand for the medicines from all around the world because of the rise in the number of covid patient’s had a positive impact on the pharmaceuticals logistics, the pharma logistics had to transform a lot because of the new development of vaccines and every vaccine’s had a different standard regarding maintenance, e.g. Pfizer vaccines need to be kept in - 8⁰C which raised the demand of the cold chain logistics.
For undeveloped nations because of the lack of infrastructure and the poor value chain management the access of vaccines and medicines weas not possible which had a major impact on the pharmaceutical’s logistics.
Drivers
The rise in the demand for the Pharmaceuticals logistics.
The continuous upgradation in the pharmaceuticals and the innovation of new drugs and medicines which further needs to be exchanged all around the globe are the factors which rise the demand for the pharmaceutical’s logistics, the pharmaceuticals logistics play an important role in delivering the drugs from the manufacturer to the end user and in this process. The increase in the number of patients suffering from various disease in the developed and the emerging countries which increase the demand for the drugs and the medicines where the pharma logistics role kicks in to deliver the drugs and medicines within time and as per the demand, which drives the demand for the pharmaceutical logistics.
Restrain.
Lack of infrastructure and economic instability.
Opportunity.
The continuous upgradation in the pharmaceutical’s logistics in terms of technology.
Impact of Ongoing Recession
Recession will cause changes in the inflation rates and which will affect the economic condition of the nation, inflation cause changes in the prices of the transportation, fuels also increase the unemployment rate and all of these has an adverse effect on the logistics and because of which recession will cause negative effect on the pharmaceutical logistic.
This report will give you an exact brief information about how recession will impact the pharmaceuticals logistics.
Segmentation Analysis
Pharmaceuticals logistics is divided into two segments by type and by component by type has two subsegments cold chain and non-cold chain logistics, in this segment non cold chain will be the segment with the highest share because of the rise in the demand for the cold chain logistics and also because of the rise in the awareness of the cold chain logistics during the Covid-19, during Covid-19 the vaccines were need to be kept under certain temperature which was mandatory and as guideline were imposed by the government health organizations, the innovation of new products to match the demand and the rising investments regarding the same is the diving factor because of which the non-cold chain logistics will be a growing sub segment during the forecasted period.
By Type:
Cold Chain Logistics
Non-Cold logistics
By Component outlook
Storage
Transportation
Monitoring Components
By Region
Europe will be the region with the highest share because of the developing cities and the need for the drugs and medicines in those regions, also the continuous development which has a direct or indirect relation are the factors which contribute to the growth of the pharmaceutical logistics market during the forecasted period, this report will give you segmental quantitative analysis region wise.
APAC region will be the region with the highest CAGR growth rate because of the initiative taken by the government to build infrastructure which will help the logistics companies to deliver the drugs efficiently and also the rise in the demand for the medicines and the drugs in the developed and the undeveloped region.
Need any customization research on Pharmaceuticals Logistics Market - Enquire Now
North America
USA
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Rest of Europe
Asia-Pacific
Japan
south Korea
China
India
Australia
Rest of Asia-Pacific
The Middle East & Africa
Israel
UAE
South Africa
Rest of Middle East & Africa
Latin America
Brazil
Argentina
Rest of Latin America
The major key players are Agility, Air Canada, CEVA logistics, DB Schenker, Deutsche Post AG, FedEX, LifeCoEX, Marken, United Parcel Service of America, Inc, VersaCold Logistics Services, and Other Players
| Report Attributes | Details |
| Market Size in 2023 | US$ 92.20 Bn |
| Market Size by 2032 | US$ 201.99 Bn |
| CAGR | CAGR of 9.59% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Type (Cold Chain logistics, Non-Cold logistics) • By Component Outlook (Storage, Transportation, Monitoring Components) |
| Regional Analysis/Coverage | North America (USA, Canada, Mexico), Europe (Germany, UK, France, Italy, Spain, Netherlands, Rest of Europe), Asia-Pacific (Japan, South Korea, China, India, Australia, Rest of Asia-Pacific), The Middle East & Africa (Israel, UAE, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) |
| Company Profiles | Agility, Air Canada, CEVA logistics, DB Schenker, Deutsche Post AG, FedEX, LifeCoEX, Marken, United Parcel Service of America, Inc, VersaCold Logistics Services, Others. |
| Key Drivers | • The rise in the demand for the Pharmaceuticals logistics. |
| Market Opportunities | • The continuous upgradation in the pharmaceutical’s logistics in terms of technology. |
Ans: The Pharmaceuticals Logistics Market is to grow at a CAGR of 9.59% over the forecast period 2023-2032.
The rise in the demand for the Pharmaceuticals logistics.
The major key players are Agility, Air Canada, CEVA logistics, DB Schenker, Deutsche Post AG, FedEX, LifeCoEX, Marken, United Parcel Service of America, Inc, VersaCold Logistics Services, Others.
Ans: The Pharmaceuticals Logistics Market size was valued at US$ 92.20 Bn in 2023.
Europe will be the region with the highest share because of the developing cities and the need for the drugs and medicines in those regions
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 COVID-19 Impact Analysis
4.2 Impact of Ongoing Recession
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Global Pharmaceuticals Logistics Market Segmentation, By Type
8.1 Cold Chain logistics
8.2 Non-Cold Logistics
9. Global Pharmaceuticals Logistics Market Segmentation, By Component Outlook
9.1 Storage
9.2 Transportation
9.3 Monitoring Components
10. Regional Analysis
10.1 Introduction
10.2 North America
10.2.1 North America Pharmaceuticals Logistics Market by country
10.2.2 North America Pharmaceuticals Logistics Market by Type
10.2.3 North America Pharmaceuticals Logistics Market by Component Outlook
10.2.4 USA
10.2.4.1 USA Pharmaceuticals Logistics Market by Type
10.2.4.2 USA Pharmaceuticals Logistics Market by Component Outlook
10.2.5 Canada
10.2.5.1 Canada Pharmaceuticals Logistics Market by Type
10.2.5.2 Canada Pharmaceuticals Logistics Market by Component Outlook
10.2.6 Mexico
10.2.6.1 Mexico Pharmaceuticals Logistics Market by Type
10.2.6.2 Mexico Pharmaceuticals Logistics Market by Component Outlook
10.3 Europe
10.3.1 Europe Pharmaceuticals Logistics Market by country
1.3.3.2 Europe Pharmaceuticals Logistics Market by Type
10.3.3 Europe Pharmaceuticals Logistics Market by Component Outlook
10.3.4 Germany
10.3.4.1 Germany Pharmaceuticals Logistics Market by Type
10.3.4.2 Germany Pharmaceuticals Logistics Market by Component Outlook
10.3.5 UK
10.3.5.1 UK Pharmaceuticals Logistics Market by Type
10.3.5.2 UK Pharmaceuticals Logistics Market by Component Outlook
10.3.6 France
10.3.6.1 France Pharmaceuticals Logistics Market by Type
10.3.6.2 France Pharmaceuticals Logistics Market by Component Outlook
10.3.7 Italy
10.3.7.1 Italy Pharmaceuticals Logistics Market by Type
10.3.7.2 Italy Pharmaceuticals Logistics Market by Component Outlook
10.3.8 Spain
10.3.8.1 Spain Pharmaceuticals Logistics Market by Type
10.3.8.2 Spain Pharmaceuticals Logistics Market by Component Outlook
10.3.9 The Netherlands
10.3.9.1 Netherlands Pharmaceuticals Logistics Market by Type
10.3.9.2 Netherlands Pharmaceuticals Logistics Market by Component Outlook
10.3.10 Rest of Europe
10.3.10.1 Rest of Europe Pharmaceuticals Logistics Market by Type
10.3.10.2 Rest of Europe Pharmaceuticals Logistics Market by Component Outlook
10.4 Asia-Pacific
10.4.1 Asia Pacific Pharmaceuticals Logistics Market by country
10.4.2 Asia Pacific Pharmaceuticals Logistics Market by Type
10.4.3 Asia Pacific Pharmaceuticals Logistics Market by Component Outlook
10.4.4 Japan
10.4.4.1 Japan Pharmaceuticals Logistics Market by Type
10.4.4.2 Japan Pharmaceuticals Logistics Market by Component Outlook
10.4.5 South Korea
10.4.5.1 South Korea Pharmaceuticals Logistics Market by Type
10.4.5.2 South Korea Pharmaceuticals Logistics Market by Component Outlook
10.4.6 China
10.4.6.1 China Pharmaceuticals Logistics Market by Type
10.4.6.2 China Pharmaceuticals Logistics Market by Component Outlook
10.4.7 India
10.4.7.1 India Pharmaceuticals Logistics Market by Type
10.4.7.2 India Pharmaceuticals Logistics Market by Component Outlook
10.4.8 Australia
10.4.8.1 Australia Pharmaceuticals Logistics Market by Type
10.4.8.2 Australia Pharmaceuticals Logistics Market by Component Outlook
10.4.9 Rest of Asia-Pacific
10.4.9.1 APAC Pharmaceuticals Logistics Market by Type
10.4.9.2 APAC Pharmaceuticals Logistics Market by Component Outlook
10.5 The Middle East & Africa
10.5.1 The Middle East & Africa Pharmaceuticals Logistics Market by country
10.5.2 The Middle East & Africa Pharmaceuticals Logistics Market by Type
10.5.3 The Middle East & Africa Pharmaceuticals Logistics Market by Component Outlook
10.5.4 Israel
10.5.4.1 Israel Pharmaceuticals Logistics Market by Type
10.5.4.2 Israel Pharmaceuticals Logistics Market by Component Outlook
10.5.5 UAE
10.5.5.1 UAE Pharmaceuticals Logistics Market by Type
10.5.5.2 UAE Pharmaceuticals Logistics Market by Component Outlook
10.5.6 South Africa
10.5.6.1 South Africa Pharmaceuticals Logistics Market by Type
10.5.6.2 South Africa Pharmaceuticals Logistics Market by Component Outlook
10.5.7 Rest of Middle East & Africa
10.5.7.1 Rest of Middle East & Asia Pharmaceuticals Logistics Market by Type
10.5.7.2 Rest of Middle East & Asia Pharmaceuticals Logistics Market by Component Outlook
10.6 Latin America
10.6.1 Latin America Pharmaceuticals Logistics Market by country
10.6.2 Latin America Pharmaceuticals Logistics Market by Type
10.6.3 Latin America Pharmaceuticals Logistics Market by Component Outlook
10.6.4 Brazil
10.6.4.1 Brazil Pharmaceuticals Logistics Market by Type
10.6.4.2 Brazil Africa Pharmaceuticals Logistics Market by Component Outlook
10.6.5 Argentina
10.6.5.1 Argentina Pharmaceuticals Logistics Market by Type
10.6.5.2 Argentina Pharmaceuticals Logistics Market by Component Outlook
10.6.6 Rest of Latin America
10.6.6.1 Rest of Latin America Pharmaceuticals Logistics Market by Type
10.6.6.2 Rest of Latin America Pharmaceuticals Logistics Market by Component Outlook
11. Company profile
11.1 Agility
11.1.1 Market Overview
11.1.2 Financials
11.1.3 Treatment/Services/Offerings
11.1.4 SWOT Analysis
11.1.5 The SNS View
11.2 Air Canada
11.2.1 Market Overview
11.2.2 Financials
11.2.3 Treatment/Services/Offerings
11.2.4 SWOT Analysis
11.2.5 The SNS View
11.3 CEVA logistics
11.3.1 Market Overview
11.3.2 Financials
11.3.3 Treatment/Services/Offerings
11.3.4 SWOT Analysis
11.3.5 The SNS View
11.4 DB Schenker
11.4.1 Market Overview
11.4.2 Financials
11.4.3 Treatment/Services/Offerings
11.4.4 SWOT Analysis
11.4.5 The SNS View
11.5 Deutsche Post AG
11.5.1 Market Overview
11.5.2 Financials
11.5.3 Treatment/Services/Offerings
11.5.4 SWOT Analysis
11.5.5 The SNS View
11.6 FedEX
11.6.1 Market Overview
11.6.2 Financials
11.6.3 Treatment/Services/Offerings
11.6.4 SWOT Analysis
11.6.5 The SNS View
11.7 LifeCoEX
11.7.1 Market Overview
11.7.2 Financials
11.7.3 Treatment/Services/Offerings
11.7.4 SWOT Analysis
11.7.5 The SNS View
11.8 Marken
11.8.1 Market Overview
11.8.2 Financials
11.8.3 Treatment/Services/Offerings
11.8.4 SWOT Analysis
11.8.5 The SNS View
11.9 United Parcel Service of America, Inc
11.9.1 Market Overview
11.9.2 Financials
11.9.3 Treatment/Services/Offerings
11.9.4 SWOT Analysis
11.9.5 The SNS View
11.10 VersaCold Logistics Services
11.10.1 Market Overview
11.10.2 Financials
11.10.3 Treatment/Services/Offerings
11.10.4 SWOT Analysis
11.10.5 The SNS View
11. Others
11.10.1 Market Overview
11.10.2 Financials
11.10.3 Treatment/Services/Offerings
11.10.4 SWOT Analysis
11.10.5 The SNS View
12. Competitive Landscape
12.1 Competitive Benchmarking
12.2 Market Share Analysis
12.3 Recent Developments
13. USE Cases and Best Practices
14. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Blood Pressure Cuffs Market size was valued at USD 192.81 Million in 2023 and is expected to reach USD 355.00 Million by 2032 and grow at a CAGR of 7.04% over the forecast period 2024-2032.
The Blockchain Technology in Healthcare Market was valued at USD 7.13 billion in 2023 and is expected to reach USD 595.31 billion by 2032 and grow at a CAGR of 63.5% over the forecast period 2024-2032.
The Interventional oncology Market Size was valued at USD 3.145 billion in 2023 and is expected to reach USD 6.862 billion by 2032 and grow at a CAGR of 9.07% over the forecast period 2024-2032.
The Biopharmaceutical CMO Market size was valued at USD 15.3 billion in 2023 and is expected to reach USD 58.2 billion by 2032 with a growing CAGR of 16% over the forecast period of 2024-2031.
The Weight Loss Drugs Market Size was valued at USD 1.92 Billion in 2023 and is expected to reach USD 45.35 Billion by 2032 and grow at a CAGR of 43.73% over the forecast period 2024-2032.
The 3D Cell Culture Market size was estimated at USD 1.37 billion in 2023 and is expected to reach USD 5.14 billion by 2031 with a growing CAGR of 14.59% during the forecast period of 2024-2031.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
